181 related articles for article (PubMed ID: 32660315)
1. Value of MRI-based radiomics analysis for differentiation of benign and malignant epithelial neoplasms in the lacrimal gland: a retrospective study.
Guo J; Li Z; Qu X; Xian J
Acta Radiol; 2021 Jun; 62(6):743-751. PubMed ID: 32660315
[TBL] [Abstract][Full Text] [Related]
2. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
Wang YZ; Xian JF; Wang XY; Guo J; Song LY
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
[No Abstract] [Full Text] [Related]
3. [Value of the apparent diffusion coefficient in diffusion weighted imaging at 3.0T MR for differentiating lacrimal gland tumors].
Wang YZ; Xian JF; Yang BT; Guo J; Wang XY; Song LY
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):53-56. PubMed ID: 30641666
[No Abstract] [Full Text] [Related]
4. Diagnostic value of dynamic contrast enhancement combined with conventional MRI in differentiating benign and malignant lacrimal gland epithelial tumours.
Jian T; Yang M; Wu T; Ji X; Xia S; Sun F
Clin Radiol; 2024 Mar; 79(3):e345-e352. PubMed ID: 37953093
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
6. Epithelial salivary gland tumors: Utility of radiomics analysis based on diffusion-weighted imaging for differentiation of benign from malignant tumors.
Shao S; Mao N; Liu W; Cui J; Xue X; Cheng J; Zheng N; Wang B
J Xray Sci Technol; 2020; 28(4):799-808. PubMed ID: 32538891
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
[TBL] [Abstract][Full Text] [Related]
8. Application of BOLD
Deng Y; Pan L; Xing W; Zhou Z; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):1010-1017. PubMed ID: 34707012
[TBL] [Abstract][Full Text] [Related]
9. A Magnetic Resonance Imaging Radiomics Signature to Distinguish Benign From Malignant Orbital Lesions.
Duron L; Heraud A; Charbonneau F; Zmuda M; Savatovsky J; Fournier L; Lecler A
Invest Radiol; 2021 Mar; 56(3):173-180. PubMed ID: 32932375
[TBL] [Abstract][Full Text] [Related]
10. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
Wang X; Wan Q; Chen H; Li Y; Li X
Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
[TBL] [Abstract][Full Text] [Related]
11. Radiomics nomogram for differentiating between benign and malignant soft-tissue masses of the extremities.
Wang H; Nie P; Wang Y; Xu W; Duan S; Chen H; Hao D; Liu J
J Magn Reson Imaging; 2020 Jan; 51(1):155-163. PubMed ID: 31169956
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of lacrimal gland tumors using the multi-model MRI: classification and regression tree (CART)-based analysis.
Li X; Wu X; Qian J; Yuan Y; Wang S; Ye X; Sha Y; Zhang R; Ren H
Acta Radiol; 2022 Jul; 63(7):923-932. PubMed ID: 34058846
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of unilateral lacrimal gland lesions.
Gündüz K; Shields CL; Günalp I; Shields JA
Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):907-13. PubMed ID: 14579116
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
15. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
Wang Y; Song L; Guo J; Xian J
Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of colour Doppler flow imaging in the management of lacrimal gland lesions.
Lecler A; Boucenna M; Lafitte F; Koskas P; Nau E; Jacomet PV; Galatoire O; Morax S; Putterman M; Mann F; Héran F; Sadik JC; Picard H; Bergès O
Eur Radiol; 2017 Feb; 27(2):779-789. PubMed ID: 27271920
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
18. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract][Full Text] [Related]
19. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
[TBL] [Abstract][Full Text] [Related]
20. Value of MR-based radiomics in differentiating uveal melanoma from other intraocular masses in adults.
Su Y; Xu X; Zuo P; Xia Y; Qu X; Chen Q; Guo J; Wei W; Xian J
Eur J Radiol; 2020 Oct; 131():109268. PubMed ID: 32947090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
